Over 30% Of Tumours In Advanced Lung Cancer Patients In Remission With Frontier Drug Teliso-V In Combination With Troche!
Significantly Longer Survival In Refractory Breast Cancer With The Addition Of Eganelisib To Standard Treatment!
FDI World Dental Federation Launches Toolkit To Make Dentistry More Sustainable
Battle-tested, this real-world data confirms the clinical efficacy of Azulfidine!
BEA-17 Granted Orphan Drug Designation By FDA For The Treatment Of Glioblastoma
Brigham and Women's Hospital, Harvard Medical School, USA
